MSC-derived Exosome CDMO Services

 

Model: 液態劑型、凍晶

Category: Cell Therapy and Regenerative Medicine

Exhibitor: GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD.

Booth No: N602

 

Characteristic

 

Gwo Xi Company is dedicated to producing pharmaceutical-grade stem cell exosomes of the golden standard.
Given our robust technology platform, our products not only exhibit exceptional biological functionality but also possess excellent druggability.
We utilize proprietary patented technology and option optimized cell line to effectively collect considerable exosomes with high quality.
Additionally, following multiple purification processes, batch testing is conducted to ensure all batches of the exosome produced are similar in their properties. The tests include nanoparticle tracking analysis (NTA), biomarker analysis, protein concentration testing, growth factor concentration testing, source cell quality identification, and sterility testing.
Ours stem cell exosome platform, combining cutting-edge technology and strict quality control, is your best choice in a manufacturing partnership.
The exosome material produced by this platform is also applying for INCI Name and TFDA make-up material.

 

Other Products

 

• 

  Stem Cell Medicine Development

• 

  DMF Verified Clinical-Grade Stem Cell

• 

  Stem Cell CDMO Services

 

 

 

Back